Discovery Laboratories, Inc. - DSCO - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Discovery Laboratories, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
DSCO	Nasdaq	8731	http://www.discoverylabs.com/	1.63 +0.01
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Discovery Laboratories, Inc. SmithOnStocks Opines On Stocks: May 19th Edition - May 19th, 2013 6:32 pm Discovery Labs Announces Completion of $14.25 Million Public Offering - May 15th, 2013 8:45 am DISCOVERY LABORATORIES INC /DE/ Financials - May 11th, 2013 11:04 am Discovery Labs to Float Stock Issue - May 10th, 2013 6:34 pm Discovery Labs Prices $14.25 Million Public Offering of Common Stock - May 10th, 2013 6:45 am DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financi - May 10th, 2013 1:35 am Discovery Labs files to sell common stock, no amount given - May 9th, 2013 2:02 pm Discovery Labs Announces Proposed Public Offering of Common Stock - May 9th, 2013 2:01 pm Discovery Labs Reports First Quarter 2013 Financial Results - May 7th, 2013 5:45 am DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Fina - May 6th, 2013 11:06 pm Looking For Opportunity - 5 Biotechs That Crashed - May 6th, 2013 11:03 am Discovery Labs Announces Recent AFECTAIR® Publications - May 1st, 2013 10:00 am Discovery Labs Announces Recent AFECTAIR® Publications - May 1st, 2013 5:45 am The FDA Issues a Stunning Rejection - Apr 29th, 2013 6:14 pm Discovery Labs Receives FDA Recommendations and Request for Clarification Regarding Recently-Submitted SURFAXIN® (lucinactant) Updated Product Specifications - Apr 16th, 2013 10:10 am Discovery Laboratories Stumbles - Apr 16th, 2013 4:09 am 3 Healthcare Stock Stories Not To Be Missed - Apr 15th, 2013 6:03 pm Discovering Yet Another Drug Delay - Apr 15th, 2013 4:50 pm Proxy Advisors Stand By Walter Energy and 4 Other Hot Stocks - Apr 15th, 2013 1:21 pm Discovery Labs plunges on new Surfaxin delay - Apr 15th, 2013 10:29 am View All Current Headlines >>